Abbott Laboratories' Attractive Valuation Ranks It Among Top Large-Cap MedTech Companies, Says Analyst
Piper Sandler initiates coverage on Abbott with an Overweight rating, citing its diversified business model, strong medtech ...
Abbott Laboratories' Best Segment Just Got Even Better: Is the Stock a Buy?
Let's not forget about Abbott Laboratories' impressive streak of 52 consecutive annual dividend increases, which also makes ...
Law3d
Who Got the Work: O'Melveny Set to Defend Abbott Labs in Digital Privacy Class Action
O'Melveny & Myers is defending Abbott Laboratories in a pending class action against the company and two other ...
Abbott Laboratories stock underperforms Wednesday when compared to competitors
The stock's fall snapped a two-day winning streak.
bovnews2d
How Does Abbott Laboratories (ABT) Stack Up Against Its Industry Peers?
Abbott Laboratories (ABT) stock saw a decline, ending the day at $114.88 which represents a decrease of $-3.25 or -2.75% from the prior close of $118.13. The stock opened at $117.5 and touched a low ...
Zacks.com on MSN2d
Abbott Stock Hurt by Macroeconomic Issues & FX Headwind
Abbott ABT is facing a challenging business environment globally. Unfavorable foreign exchange impact continues to impede ...
Abbott Laboratories stock outperforms competitors despite losses on the day
This was the stock's third consecutive day of losses.
Buy Rating on Abbott Laboratories: Undervalued with Strong Growth Prospects Despite NEC Litigation
Adam Maeder, an analyst from Piper Sandler, has initiated a new Buy rating on Abbott Laboratories (ABT). Adam Maeder has given his Buy rating ...
Abbott Laboratories: Cardiovascular Disease Has Been A Tailwind, But Things Could Change
Cardiovascular disease is rising, and Abbott Laboratories is well-positioned in the CVD treatment space. Read why I'm neutral ...
Governor Abbott delivers keys to custom home for Texas Marine in New Braunfels
Gov. Greg Abbott handed over the keys to a specially built home Saturday for U.S. Marine Corps Lance Cpl. Alberto Flores, who ...
Abbott Laboratories' (NYSE:ABT) Stock Been Rising: Are Strong Financials Guiding The Market?
Abbott Laboratories' (NYSE:ABT) stock up by 8.7% over the past three months. Since the market usually pay for a company’s long-term financial health, we decided to study the company’s fundamentals to ...